CNO (CNO) Q2 2025: Direct-to-Consumer Digital Sales Jump 39% as Middle Market Focus Deepens
CNO’s Q2 2025 results highlight a business model pivoting toward digital, with web and digital direct-to-consumer sales surging 39% and now accounting for nearly a third of D2C volume. The company’s disciplined focus on the underserved middle-income segment, stable agent-driven distribution, and prudent capital management supported record annuity and worksite sales. As CNO leans further into digital and operational efficiency, management signals confidence in sustaining growth and improving return on equity even as competitive and regulatory headwinds persist.
Summary
- Digital Channel Expansion: Web and digital sales now drive a third of D2C volume, reshaping lead generation and customer engagement.
- Distribution Model Resilience: Captive agent and worksite recruiting growth underpin steady sales momentum and client retention.
- Margin Stability Amid Competition: Prudent repricing and diversified product mix help offset spread compression and sector risk.
Performance Analysis
CNO posted a record quarter for new annualized premiums, up 17% year over year, fueled by double-digit growth across both consumer and worksite divisions. Annuity collected premiums surpassed $500 million for the first time, marking the eighth consecutive quarter of annuity growth and reflecting CNO’s deepening reach into the middle-income retirement market. Brokerage and advisory client assets rose 27% to $4.6 billion, with total entrusted assets (including annuities) now over $17 billion, up 13% year over year.
Life and health new annualized premium (NAP) advanced 17%, with direct-to-consumer (D2C) life insurance sales up 29% and field agent life sales up 4%. Web and digital channels now account for over 30% of D2C sales, up 39% year over year, while non-television lead sources continue to diversify. Worksite division delivered a sixth straight quarter of record NAP growth, with life insurance up 54% and hospital indemnity up 22%. Management emphasized operational leverage, as the expense ratio improved, and share repurchases contributed to an 8% reduction in diluted share count.
- Sales Momentum Broad-Based: Both divisions posted double-digit growth, with annuity and worksite life products leading gains.
- Agent Productivity and Retention: Producing agent count rose 3% in consumer and 4% in worksite, marking the tenth and twelfth consecutive quarters of growth, respectively.
- Investment Income Steady: Net investment income grew for the seventh straight quarter, though alternative investment returns remained below long-term targets.
Margin performance benefited from product mix and favorable claims, though Medicare Supplement (MedSupp) margins softened modestly; management is proactively filing for rate increases averaging 10% to address higher claims.
Executive Commentary
"We continue to deliver consistent, repeatable results that demonstrate the steady execution of our strategic plan and position us for sustained, profitable growth. Sales results in the quarter were excellent, including record total new annualized premiums of $120 million, up 17%, double-digit insurance sales growth in both divisions, and multiple product line sales records."
Gary Bujwani, Chief Executive Officer
"Operating earnings in the quarter and year-to-date were in line with their expectations with some puts and takes. Insurance product margins continue to benefit from consistent growth in the business, rising book yields, and net favorable claims experience across the product set. On the other hand, the yield on our alternative investments remain below our long-term run rate expectation, creating a partial offset."
Paul McDonough, Chief Financial Officer
Strategic Positioning
1. Digital Direct-to-Consumer Transformation
CNO’s pivot toward digital and web-based D2C channels is reshaping its growth trajectory. Web and digital now account for nearly a third of D2C sales, up 39% year over year, as traditional TV-based lead generation declines. Management is investing in digital marketing, third-party partnerships, and technology-driven underwriting (with instant decision rates up 12% sequentially), positioning CNO to capture evolving consumer preferences and lower acquisition costs.
2. Middle-Income Market Focus
CNO’s core business model targets the largely underserved middle-income retirement and protection market, leveraging captive agents and local engagement. The average annuity account size remains below $150,000, and the company’s distribution model provides stability, high persistency, and cross-sell opportunities. This segment focus insulates CNO from ultra-high-net-worth competition and aligns with demographic tailwinds as 11,000 Americans turn 65 daily.
3. Distribution and Agent Productivity
Agent recruiting, retention, and productivity are core levers for CNO’s growth, with both consumer and worksite divisions posting sustained increases in producing agent count. Investments in training, CRM platforms, and sales technology are driving higher productivity per agent and supporting the company’s hybrid model of personal and digital engagement. Worksite recruiting rose 34%, and new group client NAP was up 84%.
4. Prudent Capital Allocation and Risk Management
Management’s disciplined capital return strategy—with $117 million returned to shareholders in Q2 and $234 million year-to-date—reflects confidence in free cash flow and risk-based capital (RBC) stability. The company is maintaining high portfolio quality (96% investment grade), managing spread compression, and actively repricing MedSupp products to offset claims pressure. Ongoing regulatory engagement in Bermuda signals further optimization opportunities for ROE accretion.
5. Resilience in Competitive and Regulatory Environments
CNO differentiates itself from headline risk in Medicare Advantage and annuity markets, emphasizing its focus on MedSupp manufacturing (with annual repricing) and diversified carrier distribution for MA. Management highlighted minimal concentration risk (20 MA carriers) and a business model insulated from regulatory and underwriting volatility affecting peers.
Key Considerations
This quarter reinforces CNO’s multi-pronged strategy: digital transformation, middle-market specialization, and operational rigor. Investors should track the sustainability of these drivers as competitive and macro conditions evolve.
Key Considerations:
- Digital Channel Scaling: Sustained web and digital D2C growth is critical for future lead generation efficiency and customer acquisition costs.
- Agent Channel Productivity: Continued investment in training and technology is vital to maintain agent momentum and sales conversion rates.
- Spread and Margin Management: While core product spreads remain stable, alternative investment returns and MedSupp claims trends require ongoing vigilance.
- Capital Flexibility: Share repurchases and prudent RBC management support shareholder returns but may face headwinds if investment income or claims trends deteriorate.
- Regulatory and Competitive Positioning: CNO’s differentiated approach to MedSupp and MA distribution mitigates sector headline risk, yet ongoing rate and regulatory changes warrant close monitoring.
Risks
Key risks include continued spread compression in a lower rate environment, the possibility of digital channel growth plateauing, and adverse claims trends—particularly in Medicare Supplement and long-term care—that could pressure margins. Regulatory actions, especially regarding Medicare products, and intensifying competition from asset managers in annuities represent additional uncertainties. Management’s proactive repricing and diversified distribution help mitigate some, but not all, of these risks.
Forward Outlook
For Q3 2025, CNO guided to:
- Sustained sales momentum across both divisions, with comparable growth rates facing tougher year-over-year comparisons.
- Continued improvement in operating leverage, with the upper bound of the expense ratio range lowered to 19.2%.
For full-year 2025, management reaffirmed guidance:
- Operating return on equity target of 10.5% for 2025, with a path to 11.5% by 2027.
Management highlighted several factors that will shape the second half:
- Digital and web channel expansion is expected to continue, though not at Q2’s 39% pace.
- MedSupp repricing (average 10% rate increase) will take effect next year, helping offset claims trends.
Takeaways
Investors should recognize CNO’s digital and middle-market franchise as a durable differentiator, with agent distribution and product mix providing stability. Margin and capital management remain disciplined, but alternative investments and healthcare claims trends require monitoring.
- Digital and Agent Model Synergy: The blend of digital lead generation and local agent engagement is unlocking new growth vectors and operational efficiencies.
- Margin Management in Focus: Proactive repricing and diversified product exposure help CNO manage through claims volatility and spread compression.
- Watch for Execution on Digital, Claims, and Capital: Sustaining digital growth, maintaining agent productivity, and delivering on capital return targets will be key for valuation support in coming quarters.
Conclusion
CNO’s Q2 2025 results showcase a business executing on digital transformation and middle-market specialization, with resilient sales, disciplined capital management, and a measured approach to risk. Sustained agent productivity and digital channel growth remain pivotal to the company’s long-term trajectory.
Industry Read-Through
CNO’s digital channel acceleration and stable agent-driven model highlight a broader insurance industry shift toward hybrid distribution. The company’s ability to maintain sales momentum and margin stability in the face of MedSupp and annuity competition signals that focused, middle-market strategies can outperform amid sector volatility. Peers with high exposure to Medicare Advantage manufacturing or undifferentiated annuity distribution may face greater regulatory and margin headwinds. The trend toward digital lead generation and operational leverage is likely to persist across the life and health insurance sector, with technology investments and agent productivity emerging as key competitive battlegrounds.